This research provides new tools for understanding and communicating the value of federally-funded genomic research.
Better ROI Measurement
Move beyond citation-based metrics to capture actual knowledge use in pharmaceutical innovation. Text mining reveals the real scientific content driving R&D.
Quantify Spillovers
For the first time, rigorously measure how basic science discoveries propagate through biological networks to enable innovation beyond direct targets.
Justify Investment
Demonstrate that the true impact of GWAS is substantially larger than direct outcomes alone—providing evidence for continued funding of basic genomic research.